International Stem Cell Corporation
Carlsbad
About International Stem Cell Corporation
International Stem Cell Corporation (ISCO) is a publicly traded biotechnology company with a powerful new stem cell technology called parthenogenesis which uses unfertilized eggs, and promises to significantly advance the field of regenerative medicine by addressing the problem of immune-rejection. They are focused on using these stem cells to treat diseases of the eye, the nervous system and the liver, where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells or tissue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2014)
- Ticker: otcqb:ISCO
- Website: internationalstemcell.com
- Phone: (760) 940-6383
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/international-stem-cell-corporation-1208775 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.